PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
CEO, CFO securities liability Section 20(a) control person claims focus on allegations that PROCEPT BioRobotics senior leaders certified and controlled public statements while PRCT investors allegedly suffered a more than 75% decline.
Levi & Korsinsky, LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed on behalf of shareholders who purchased securities between February 28, 2024 and February 25, 2026. Find out if you may qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
PRCT shares declined more than 75%, from approximately $100.00 during the Class Period to less than $25.00 after the Class Period, an alleged loss of more than $75.00 per share. To be considered for lead plaintiff, investors must file by September 22, 2026.
CEO, CFO Securities Liability Section 20(a) Control Person Claims






